表紙
市場調査レポート

小児科用ドラッグデリバリー:技術および製品の機会(第2版)

Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition

発行 MCD Group, LLC 商品コード 134093
出版日 ページ情報 英文
即納可能
価格
こちらの商品の販売は終了いたしました。
Back to Top
小児科用ドラッグデリバリー:技術および製品の機会(第2版) Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
出版日: 2010年10月04日 ページ情報: 英文

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当レポートでは、小児科用ドラッグデリバリー市場に関するデータ、主要企業、医薬品情報、ドラッグデリバリー技術プロファイル、提携の機会などについてまとめ、概略下記の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 小児科市場概要

  • 市場のニーズ
  • 治療ニーズ
  • 市場規模
  • 主な治療分野

第3章 小児科用ドラッグデリバリーシステム(DDS)

  • 上市製品
  • 投与方法

第4章 処方の機会

  • 経口薬処方
  • 味覚マスキング
  • 非侵襲処方

第5章 小児科マーケティングに注目する企業

  • Adams Respiratory Therapeutics LLC
  • Aires Pharmaceuticals, Inc.
  • Arbor Pharmaceuticals, Inc.
  • Asklepion Pharmaceuticals, Inc.
  • Centrix Pharmaceutical, Inc.
  • Cornerstone Therapeutics, Inc.
  • Curemark, LLC
  • FSC Pediatrics Inc.
  • InfaCare Pharmaceutical Corporation
  • Lupin Pharmaceuticals, Inc.
  • Madeira Therapeutics
  • McNeil Pediatrics
  • Meritage Pharma, Inc.
  • Next Wave Pharmaceuticals, Inc.
  • ParaPRO LLC
  • Pediapharm, Inc.
  • Pernix Therapeutics Holdings, Inc.
  • Reckitt Benckiser Pharmaceutical, Inc
  • Seaside Therapeutics, Inc.
  • 塩野義製薬
  • TaroPharma
  • Teva Specialty Pharmaceuticals LLC
  • Tiber Laboratories, LLC
  • Topaz Pharmaceuticals Inc
  • TRx Pharma

第6章 小児科用薬剤のドラッグデリバリー技術

  • 口腔デリバリーシステム
  • 経口
  • 味覚マスキング技術
  • 経鼻投与技術
  • 経皮デリバリー技術

第7章 製品ライセンシングの機会

目次

According to the report Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition, there is a strong need for development and commercialization of pediatric-friendly formulations. Presently, there are not enough marketed formulations that are suitable for pediatric patients and this report hopes to increase awareness of the unmet needs in the pediatric segment while also providing actionable information for formulation and marketing companies.

In order to facilitate development and commercialization of new pediatric products, this report identifies therapeutic categories where the need exists for pediatric-friendly formulations (easy to swallow formulations such as liquids and dissolvable tablets) and provides examples of specific drugs that are candidates for reformulation. Some of the key therapeutic categories discussed in this report include cardiovascular disease, diabetes, epilepsy, pain management, and respiratory illnesses; all of which have a growing incidence among pediatric patients. In addition, the report profiles specialty pharmaceutical companies focused on pediatrics, many of which have an interest in forming strategic partnerships for the co-development and/or marketing of new pediatric products. Finally, pediatric pipeline products are identified as well as multiple pediatric-focused products which are available for partnering in one or more major markets.

As drug delivery technologies play a very important role in pediatric medicine, this report provides detailed profiles of novel drug delivery technologies that can be used to formulate pediatric-friendly products. More than 70 different delivery technologies are covered in this report and include orally disintegrating tablets and films, taste masked suspensions, soft chewable delivery systems, topical foam systems, and controlled release liquids.

This 250+ page report provides a comprehensive overview of the pediatric drug delivery market and includes relevant market data, key players, pharmaceutical product information, drug delivery technology profiles, and partnering opportunities.

Report Contents:

1. Analysis of US Pediatric Market (2009)

  • Discussion of pediatric market size and needs
  • Rx Pediatric Market Size
  • Sales of 25 common drugs prescribed to pediatrics (2009 sales)
  • Sales of leading pediatric-focused products (2009 sales)
  • Sales of key products in therapeutic categories applicable to pediatrics (ADHD, Antibiotics, Allergies, etc.)

2. Drug Delivery Systems for Pediatrics

  • Marketed Products
    • DDS products approved for pediatric use
    • OTC DDS products approved for pediatrics
  • Dosage Forms and Technologies
    • Taste masking, orally disintegrating dosage forms, soft chewable delivery systems, oral liquids, oral mucosal systems, transdermal and topical systems, nasal and pulmonary delivery, parenteral and device technologies
    • Pediatric pipeline products by formulation type

3. Formulation Opportunities in the Pediatric Segment

  • Oral reformulation
  • Taste masking
  • Dosage form changes

4. Profiles of Specialty Pharma Companies with Pediatric Focus

  • 25 company profiles including: Arbor Pharmaceuticals, Curemark, Madeira Therapeutics, FSC Laboratories, and Pediapharm Inc.

5. Profiles of 70+ Drug Delivery Technologies Applicable to Pediatric Medicine

6. Pediatric Product Licensing Opportunities

  • 35+ licensing opportunities including: Orally-disintegrating allergy products, novel head lice treatments, pediatric foam products, and cough/cold formulations

Table of Contents

1. Executive Summary

  • Market Overview
  • Drug Delivery Systems for Pediatrics
  • Formulation Opportunities
  • Specialty Pediatric Companies
  • Product Licensing Opportunities

2. Pediatric Market Overview

  • Market Needs
  • Therapeutic Needs
    • Hypertension
    • Hypercholesterolemia
    • Diabetes
    • Pain Management
    • Anti-Infectives
    • Respiratory / Allergy
    • Attention Deficit Hyperactivity Disorder
    • Epilepsy
  • Market Size
  • Key Therapeutic Areas
    • CNS
    • Allergies
    • Asthma
    • Infections

3. Drug Delivery Systems for Pediatrics

  • Marketed Products
  • Dosage Forms
    • Taste Masking
    • Orally Disintegrating Dosage Forms
    • Soft Chewable Delivery Systems
    • Oral Liquid Delivery Systems
    • Oral Mucosal Delivery Systems
    • Transdermal Delivery Systems
    • Topical Delivery Systems
    • Nasal Drug Delivery
    • Pulmonary Delivery Systems
    • Parenteral and Device Technologies

4. Formulation Opportunities

  • Oral Reformulation
  • Taste Masking
  • Non-invasive Formulations

5. Companies with Pediatric Focus

  • Adamis Pharmaceuticals Corporation
  • Aires Pharmaceuticals, Inc.
  • Arbor Pharmaceuticals, Inc.
  • Asklepion Pharmaceuticals, Inc.
  • Centrix Pharmaceutical, Inc.
  • Cornerstone Therapeutics, Inc.
  • Curemark, LLC
  • FSC Pediatrics, Inc.
  • InfaCare Pharmaceutical Corporation
  • Lupin Pharmaceuticals, Inc.
  • Madeira Therapeutics
  • McNeil Pediatrics
  • Meritage Pharma, Inc.
  • Next Wave Pharmaceuticals, Inc.
  • ParaPRO, LLC
  • Pediapharm, Inc
  • Pernix Therapeutics Holdings, Inc
  • Reckitt Benckiser Pharmaceutical, Inc
  • Seaside Therapeutics, Inc.
  • Shionogi Pharma, Inc.
  • TaroPharma
  • Teva Respiratory, LLC
  • Tiber Laboratories, LLC
  • Topaz Pharmaceuticals, Inc
  • TRx Pharma

6. Drug Delivery Technologies for Pediatric Drugs

  • Buccal Delivery Systems
    • APTYS Pharmaceuticals
    • Biodel, Inc.
    • BioDelivery Sciences International
    • Corium International, Inc
    • Fertin Pharma
    • NovaDel Pharma
    • Orexo AB
    • ULURU, Inc
    • Watson, Inc.
  • Oral Delivery Systems
    • Acino Holding, Ltd.
    • Akina, Inc.
    • Alpex Pharma
    • Alte Biosciences, Inc
    • Aprecia Pharmaceuticals Company
    • Arx, LLC
    • Banner Pharmacaps
    • Capricorn Pharma, Inc.
    • Catalent Pharma Solutions
    • CIMA Labs, Inc
    • Collegium Pharmaceutical, Inc.
    • Dow Wolff Cellulosics
    • Egalet A/S
    • Ethypharm
    • Eurand, Inc
    • Eurand, Inc
    • ForTe BV
    • Grunenthal GmbH
    • HealthSport, Inc
    • IntelGenx Corporation
    • KV Pharmaceutical Company
    • Labtec Pharma
    • Lavipharm
    • Losan Pharma GmbH
    • LTS Lohmann
    • Meldex International, PLC
    • MonosolRx
    • NAL Pharmaceuticals, Ltd.
    • Pharmafilm S.r.l.
    • Physica Pharma
    • SPI Pharma Inc.
    • Tris Pharma
    • Xel Pharmaceuticals, Inc.
  • Taste Masking Technologies
    • Balchem Corporation
    • Cambrex Corporation
    • Ethypharm
    • Eurand, Inc
    • ForTe BV
    • Oralance Pharma
  • Nasal Technologies
    • Ikano Therapeutics, Inc.
    • OptiNose
  • Dermal Delivery Technologies
    • Altea Therapeutics
    • Foamix, Ltd
    • ForTe BV
    • Intercell
    • nanoBioSciences, LLC
    • Pantec Biosolutions
    • Quinnova Pharmaceuticals, Inc.
    • TransPharma Medical
    • Zosano Pharma

7. Product Licensing Opportunities

  • Albuterol Dry Powder Inhaler
  • Allergy Chewing Gum
  • Atopic Dermatitis Treatment
  • Atopiclair™ Cream
  • CRO-PED for Pediatric Diarrhea
  • Children' s Dietary Supplement
  • Ciprofloxacin Otic Solution
  • Cough/Cold Pediatric Formulations
  • Decongestant Cream Stick
  • Decongestant Patch
  • Fever Cooling Patch
  • Foam-Based Dermatology Products
  • Foam-Based Products for Infants
  • GastroGard-R for Rotavirus
  • Hedrin™ for the Treatment of Head Lice
  • Human Growth Hormone Nasal Spray
  • Insect Repellent Patch
  • Insecticide-Free Head Lice Treatment
  • Liposomal Amikacin Formulation
  • Long-acting Somatropin Injection
  • Moisturizing Cream for Dermatitis
  • Nasal Somatropin Formulation
  • NeoCeram™ Skin Barrier Emulsion
  • Novel Head Lice Formulation
  • Once-weekly Injectable Somatropin
  • Oral Film Formulation of Prednisolone
  • Oral Rotavirus Thin Film Product
  • Orally Disintegrating Acetaminophen Formulations
  • Orally Disintegrating Allergy Products
  • Pediatric Pain Formulations
  • Peptide for Chronic Middle Ear Infections
  • Sinlice, Pediculicide Treatment
  • Site-Specific Otitis Media Treatment
  • Sustained Release Somatropin Injection
  • Teething Gel for Babies
  • Zinc Oxide Spray
Back to Top